↑

International Patients: +91 8743024344 · Indian Patients: +91 7838223336 · Patient Reviews · Leave a Google Review ★

Hypoxic Ischemic Encephalopathy · Stem Cell Therapy

Hypoxic Ischemic Encephalopathy Stem Cell Treatment in Delhi, India

Stem cell therapy for Hypoxic Ischemic Encephalopathy is an investigational approach being studied alongside standard medical care, with potential benefits varying depending on the type and severity of the injury.

Get Free Medical Evaluation → · Upload Medical Reports → · Latest Blog on Hypoxic Ischemic Encephalopathy →

10,000+ patients treated worldwide
Stem Cell Care India doctor reviewing before-and-after brain scans on a tablet with a patient and family member during a hypoxic ischemic encephalopathy stem cell therapy consultation
10,000+ Patients treated
65+ Countries served
Certified Accredited hospitals & labs
16+ Years GMP-certified cell processing

Quick Answer

Researchers are studying stem cell therapy for hypoxic ischemic encephalopathy (HIE) for its possible neuroprotective and anti-inflammatory effects, which may help limit secondary brain injury following an oxygen-deprivation event. Findings remain early-stage and vary across studies, and outcomes largely depend on the severity and timing of the original hypoxic injury. A thorough pediatric neurology evaluation is essential before considering this investigational option.

Key Takeaways

On this page — 6 categories, 27 topics

01

What Stem Cell Therapy for Hypoxic Ischemic Encephalopathy Is

Hypoxic ischemic encephalopathy (HIE) is a serious form of brain injury that occurs when an infant's brain does not receive enough oxygen and blood flow, most often around the time of birth. Depending on severity, it can lead to lasting neurological impairment affecting movement, cognition, and overall development.

Conventional care for HIE is largely supportive, centered on therapeutic hypothermia — controlled cooling of the body soon after birth to slow metabolic activity and limit further neuronal injury. While cooling therapy can reduce the extent of damage when started early, it does not repair tissue that has already been affected, which is why researchers continue to look for approaches that support genuine tissue repair.

Stem cell therapy is being explored as one such approach. Cells such as mesenchymal stem cells and neural stem cells are of particular interest because they may differentiate into supporting brain cell types and release factors associated with reduced inflammation and neuron protection. Much of this evidence currently comes from laboratory and animal studies, with early-phase human trials underway to evaluate safety and feasibility, so results in infants remain preliminary and should be interpreted with caution.

02

Symptoms of Hypoxic Ischemic Encephalopathy

Symptoms of HIE vary with the severity and duration of oxygen deprivation and are generally described in terms of immediate newborn signs and longer-term developmental effects.

  • Low Apgar Scores — Reduced scores for heart rate, tone, reflexes, and breathing shortly after birth.
  • Breathing Difficulty — Some infants require resuscitation or breathing support at birth.
  • Seizures — Often appear within the first 24 to 48 hours of life.
  • Abnormal Muscle Tone — Either unusually floppy (hypotonia) or unusually stiff (hypertonia) muscle tone.
  • Feeding Difficulties — Trouble with sucking or swallowing in the newborn period.
  • Reduced Alertness — Lethargy or a reduced level of consciousness in the days after birth.
  • Developmental Delays — Slower progress reaching milestones such as crawling, walking, or speaking.
  • Motor Impairments — Cerebral palsy and coordination difficulties are among the more common long-term effects.
  • Seizure Disorders — Some children go on to develop epilepsy.
  • Behavioral and Sensory Issues — Attention difficulties, hyperactivity, and vision or hearing impairment may also appear over time.
03

Types of Hypoxic Ischemic Encephalopathy

HIE is generally classified by severity, which helps guide treatment decisions and gives a general sense of expected outcomes.

  • Mild HIE — Involves subtle, short-lived symptoms such as irritability or mild feeding difficulty, usually resolving within 24 hours with a generally favorable outlook.
  • Moderate HIE — Presents with lethargy, reduced muscle tone, and seizures; with prompt treatment such as therapeutic hypothermia, many infants recover well, though the risk of longer-term neurological effects is higher than in mild cases.
  • Severe HIE — The most serious form, marked by a comatose or unresponsive state, frequent seizures, and difficulty feeding or breathing; this form carries a higher risk of significant, lasting neurological impairment.
  • Sarnat and Sarnat Grading — A staging system (Stage I–III) that categorizes HIE severity based on clinical and EEG findings, broadly corresponding to mild, moderate, and severe disease.
04

Causes of Hypoxic Ischemic Encephalopathy

HIE results from reduced oxygen and blood flow to the brain, which can occur before, during, or shortly after birth. Understanding the underlying trigger helps guide monitoring and care.

  • Placental Complications — Conditions such as placental abruption or placental insufficiency can reduce oxygen and nutrient delivery to the fetus.
  • Umbilical Cord Complications — Cord prolapse, nuchal cord, or true knots can restrict blood flow during labor.
  • Prolonged or Difficult Labor — Extended labor with fetal distress, or complications such as shoulder dystocia, can lead to oxygen deprivation.
  • Maternal Health Conditions — Chronic conditions such as hypertension, diabetes, or preeclampsia can impair blood flow to the fetus.
  • Infections — Maternal or neonatal infections can trigger inflammation that impairs oxygen delivery to the brain.
  • Respiratory or Cardiac Problems After Birth — Conditions such as respiratory distress syndrome or congenital heart defects can reduce oxygenated blood flow to the newborn brain.
  • Preterm or Post-Term Birth — Both premature and significantly overdue births carry elevated risk due to organ immaturity or reduced placental efficiency, respectively.
05

How Hypoxic Ischemic Encephalopathy Is Diagnosed

Because early identification supports more effective intervention, diagnosis of HIE typically draws on a combination of clinical assessment, laboratory testing, and imaging.

  • Apgar Scoring — Assessed at one and five minutes after birth to gauge the newborn's immediate condition.
  • Neurological Examination — Evaluates alertness, muscle tone, reflexes, and any seizure activity.
  • Blood Gas and Lactate Testing — Helps confirm oxygen deprivation and its metabolic effects.
  • Cranial Ultrasound — Often the first imaging test used, given its safety and accessibility.
  • MRI with Diffusion-Weighted Imaging — Highly sensitive for detecting early brain injury and assessing its extent.
  • Electroencephalography (EEG) — Continuous or amplitude-integrated EEG monitors brain activity and helps detect seizures.
  • Umbilical Cord Blood Analysis — Provides immediate information about the newborn's oxygenation status at delivery.
06

How Stem Cell Therapy Is Approached as a Treatment for Hypoxic Ischemic Encephalopathy

Standard care for HIE begins with immediate stabilization — supporting breathing and circulation — followed by therapeutic hypothermia when started within the first hours of life, which can help limit the extent of injury. Ongoing care includes seizure management, nutritional support, and respiratory support as needed.

Stem cell therapy is being explored as a supportive, investigational option alongside these standard measures. The intention is to draw on cells that may help calm inflammation, support existing neurons, and, over time, contribute to repair of affected brain tissue. Cells used in this approach may be sourced from umbilical cord blood, bone marrow, or other tissue, and are typically introduced intravenously or, in some research settings, closer to the central nervous system. This remains an experimental approach, and ongoing studies continue to examine safety, timing, and effectiveness.

07

How It's Being Explored for Hypoxic Ischemic Encephalopathy

Stem cell therapy's potential in HIE is attributed to several interrelated mechanisms that support brain repair and recovery:

  • Neuroregeneration — Mesenchymal and neural stem cells can differentiate into neurons, astrocytes, and oligodendrocytes, potentially replacing cells lost to hypoxic injury.
  • Neuroprotection — Stem cells release neurotrophic factors such as BDNF and GDNF that support neuron survival, and can help inhibit programmed cell death pathways.
  • Anti-Inflammatory Effects — Stem cells may help reduce pro-inflammatory cytokines while boosting anti-inflammatory ones, and can modulate immune cell activity to limit harmful inflammation.
  • Angiogenesis — Stem cells secrete factors such as VEGF that stimulate new blood vessel formation, improving oxygen and nutrient delivery to injured brain tissue.
  • Reduction of Oxidative Stress — Stem cells may help neutralize free radicals and support the brain's own antioxidant defenses.
  • Paracrine Effects — Stem cells release exosomes and microvesicles that carry proteins, lipids, and RNA which can help modulate cell function and support repair.
  • Enhanced Synaptic Connectivity — Stem cells may support formation of new neuronal connections and improve signal transmission, important for cognitive and motor function.
08

What the Hypoxic Ischemic Encephalopathy Treatment Process Looks Like

Day 1

  • Pick up from the Airport to the Hospital
  • Interaction between Dr and Patient to clear all doubts
  • Admission procedure
  • Clinical examination & lab tests prescribed by the doctor
  • Supportive Therapy

Day 2

  • Stem cell Procedure
  • Supportive therapies
  • Physiotherapy

Day 3

  • Supportive Therapy
  • Physiotherapy
  • Discharging formalities
  • Drop back to the Airport

Note: For Admission, carry the identity card (Passport/Pan Card/Driving License) and hard copies of patient reports.

09

Delivery Techniques Used in Stem Cell Therapy for Hypoxic Ischemic Encephalopathy

Doctors consider several delivery methods for administering stem cells in HIE, based on the cell type, the severity of the condition, and the infant's overall health.

  • Intravenous Administration — Cells are delivered into a vein and travel through the bloodstream toward the brain, a widely used and minimally invasive technique.
  • Intrathecal Administration — Cells are introduced directly into the cerebrospinal fluid, offering more direct access to the central nervous system.
  • Intra-Arterial Administration — Cells are delivered into an artery supplying the brain, allowing targeted delivery to the site of injury under careful monitoring.
  • Timing of Administration — Early intervention, generally within the first days of life, is considered important, since the therapeutic window may be most favorable during this period.
10

Changes Hypoxic Ischemic Encephalopathy Patients Sometimes Report

Stem cell treatment for HIE has shown encouraging results across several aspects of neurological function in affected infants, though the degree of improvement varies with the severity of the condition and details of the treatment protocol. Reported areas of potential improvement include:

  • Motor Skills — Increased muscle tone and control, with better coordination supporting milestones like sitting, crawling, and walking.
  • Cognitive Development — Improvements in attention, memory, and problem-solving, along with better language and communication skills.
  • Seizure Reduction — A decrease in the frequency and severity of seizures in many patients.
  • Sensory Processing — Better integration and response to sensory input such as touch, sight, and sound, along with more normalized reflexes.
  • Fine and Gross Motor Skills — Better control of small movements such as grasping, and larger movements such as rolling over and sitting up.
  • Behavioral and Emotional Development — Reduced irritability, improved sleep patterns, and better emotional regulation.
  • Feeding and Growth — Improved sucking and swallowing ability, supporting healthier growth.
  • Developmental Milestones — Faster and more consistent achievement of developmental milestones compared with infants who do not receive stem cell treatment.
  • Long-Term Outcomes — Improved school readiness, social interaction, and independence in daily activities over time.

These improvements are attributed to several mechanisms, including neuroprotection, neuroregeneration, anti-inflammatory effects, and enhanced synaptic connectivity — outlined further in the Mechanism section below.

11

Is Stem Cell Therapy Safe for Hypoxic Ischemic Encephalopathy?

Stem cell therapy for Hypoxic Ischemic Encephalopathy is discussed only after an individual medical evaluation, and safety depends heavily on that case-by-case review rather than on the therapy in general. As with any medical intervention, mild and temporary reactions (such as soreness or fatigue at the injection or infusion site) are possible, and a full risk discussion happens as part of your evaluation. It is not offered to patients in an acute or unstable phase of Hypoxic Ischemic Encephalopathy, and it is never positioned as a substitute for guideline-based care from your treating specialist. For a fuller picture of how safety, accreditation, and quality standards are handled, see our Safety and Guarantees page.

12

Who Might Consider a Hypoxic Ischemic Encephalopathy Discussion — and Who Should Not

May be reasonable to discuss

  • A confirmed hypoxic ischemic encephalopathy diagnosis, with the patient medically stable and not in an acute emergency
  • Prior imaging, neurology, and treatment records available for review
  • The injury is past its acute phase, with the patient in a stable, chronic-care stage
  • Realistic expectations that any benefit would be supportive and investigational, not a cure
  • Willingness to continue rehabilitation and follow-up care alongside this discussion

Generally not appropriate

  • Acute or unstable neurological emergencies requiring immediate critical care
  • Active untreated infection, uncontrolled bleeding disorder, or advanced organ failure
  • An active, untreated malignancy that has not been cleared by an oncologist
  • Pregnancy, or an expectation that the therapy will reverse or cure the underlying condition
  • Unwillingness to share prior medical records or to be evaluated before proceeding

This list is general and educational — it is not a substitute for an individual medical evaluation of your case.

13

What a Hypoxic Ischemic Encephalopathy Supportive-Care Discussion Involves

A supportive-care discussion for Hypoxic Ischemic Encephalopathy isn't a single conversation — it follows a defined sequence, so nothing is recommended before your specific case has been reviewed. In broad terms:

  1. Record review: Your existing diagnosis, imaging, lab work, and treatment history for Hypoxic Ischemic Encephalopathy are reviewed by the medical team first.
  2. Case-by-case medical evaluation: A physician assesses whether any further discussion is medically reasonable for your specific case — many enquiries end here with a clear "not appropriate" answer, which is a valid and expected outcome.
  3. Coordination with your specialist: Where a discussion proceeds, it is coordinated so it does not conflict with your ongoing care from your treating specialist.
  4. Transparent, written explanation: Any recommendation is explained in plain language, including its investigational status, realistic expectations, and that no outcome is guaranteed.
  5. Ongoing standard care continues: At every stage, your prescribed treatment for Hypoxic Ischemic Encephalopathy continues unless your own treating specialist changes it.

Nothing is scheduled or billed during this stage — it is a review and conversation, not a commitment.

14

Our Approach to Hypoxic Ischemic Encephalopathy Care

Families facing HIE are often looking for hope in effective treatment options. Stem Cell Care India aims to provide compassionate care, proper guidance, safe treatment procedures, and individualized attention for those exploring HIE stem cell treatment in India.

How We Keep Our Promise

  • Patient assessment is carried out before therapy so doctors have a clear picture of the infant's condition.
  • We use current techniques and technology to support treatment outcomes.
  • Constant monitoring and follow-up assistance are provided after treatment.
  • Therapeutic programs support gradual physical and cognitive recovery.
  • We aim to keep communication open with family members about the process, expectations, and progress.
  • We aim to offer emotional support, recognizing that families of children with HIE often need encouragement.
15

Cost and How Stem Cell Therapy Compares for Hypoxic Ischemic Encephalopathy

HIE can be a serious and disruptive condition for a child and family, so Stem Cell Care India aims to offer an affordable, cost-effective treatment program tailored to the patient's needs. Overall cost varies based on the patient's condition, number of treatment sessions, therapy required, and length of hospital stay.

Factors That Affect Cost of the Treatment

  • Severity of the Condition — More severe symptoms may require additional care, medication, and treatment, increasing cost.
  • Number of Stem Cell Treatment Sessions — Some patients may need more than one session.
  • Length of Hospital Stay — Additional days in hospital increase overall cost.
  • Other Treatment Options — Physiotherapy, occupational therapy, speech therapy, and rehabilitation add to the total.
  • Tests and Evaluations — Pre-treatment tests and evaluations recommended by physicians also factor into cost.
16

What Influences Hypoxic Ischemic Encephalopathy Outcomes

Brain damage from oxygen deprivation at birth can lead to developmental challenges, which is why some parents consider stem cell treatment for HIE in India. Effectiveness varies by individual depending on the degree of brain damage, age, and health status. Some patients see improvement in motor skills, coordination, speech, concentration, and responsiveness, supported further by rehabilitation care.

Factors That Affect Success Rate

  • Severity of Brain Damage — More severe damage may mean a slower recovery process; milder cases tend to have a better chance of improvement.
  • Age of the Patient — Younger children sometimes show better results.
  • Early Initiation of Therapy — Starting stem cell therapy at an earlier stage may support better recovery.
  • General Health Status — Good nutrition and a strong immune system may support healing.
  • Rehabilitative Techniques — Combining physiotherapy, speech therapy, and occupational therapy with stem cell therapy may enhance recovery.
  • Number of Sessions — Some patients may need more than one session depending on their condition.
  • Post-Procedure Care — Consistent monitoring and proper care after the procedure support long-term recovery.
17

Why Hypoxic Ischemic Encephalopathy Patients Consider Treatment in India

Stem cell treatment is an emerging option for HIE, a condition marked by brain injury from lack of oxygen and blood flow. Potential advantages include:

  • Neuroregeneration and Repair — Stem cells can differentiate into neural cell types, potentially replacing damaged or lost cells and helping restore brain tissue.
  • Neuroprotection — Release of neurotrophic factors may protect existing neurons and help prevent further cell loss.
  • Reduction of Inflammation — Anti-inflammatory properties may help limit secondary damage to brain tissue.
  • Seizure Reduction — Some infants show decreased frequency and severity of seizures following treatment.
  • Enhanced Cognitive and Motor Function — Potential improvements in muscle tone, coordination, attention, memory, and problem-solving.
  • Sensory Processing Improvement — Better sensory integration and more normalized reflexes.
  • Overall Health and Quality of Life — Improvements in feeding, growth, and reduced need for prolonged hospitalization have been reported.
  • Minimally Invasive, Safer Options — Common delivery methods such as IV or intrathecal injection are minimally invasive, and using the patient's own (autologous) cells can reduce the risk of immune rejection.
18

Quality Control in Cell Processing for Hypoxic Ischemic Encephalopathy Therapy

Quality control in stem cell therapy for HIE aims to ensure safety and effectiveness through processes such as:

  • Cell Source Verification — Confirming stem cells come from an appropriate, suitable source.
  • Culture and Expansion Monitoring — Regular checks during cell culture to maintain correct growth conditions and prevent contamination.
  • Genetic and Phenotypic Testing — Assessing genetic stability and cell identity to confirm cells meet predefined criteria.
  • Viability and Potency Assays — Testing cell viability and function to ensure cells remain effective.
  • Endotoxin and Contamination Screening — Ensuring cells are free from bacterial endotoxin and other contaminants.
  • Sterility Testing — Validating the sterility of the final cell product before use.
  • Clinical Oversight — Trials and treatment protocols are monitored under regulatory guidelines, with outcomes tracked to refine safety and efficacy.
19

What Hypoxic Ischemic Encephalopathy Patients May Notice After Treatment

Stem cell treatment for HIE in India is regarded by some parents as a hopeful option for supporting their infant's physical and neurological development, though outcomes vary depending on factors like age, extent of damage, and rehabilitation efforts.

  • Many patients show improvement in motor skills and balance, becoming steadier when sitting, standing, or walking with support.
  • Some parents observe progress in communication, including improved eye contact, voice recognition, and understanding of simple commands.
  • Gradual improvements in cognitive skills such as memory, learning, and focus have been observed in some cases.
  • Decreased muscle tension and spasticity have been noted in a few individuals, making daily activities easier.
  • Some patients show improved feeding and swallowing ability.
  • Improvements in sleep patterns and behavior are occasionally reported, with children appearing calmer and more socially engaged.
  • Combining physiotherapy, occupational therapy, and speech therapy with stem cell therapy may support better outcomes.
  • Doctors typically monitor patient progress closely after treatment.
20

Quality Certification for Hypoxic Ischemic Encephalopathy Therapy

Quality and safety considerations are important for families researching stem cell therapy for HIE in India. Stem Cell Care India aims to provide treatment from a center that maintains quality medical standards and certification processes.

Strict quality control processes are followed at every step of treatment. Laboratory processing, stem cell storage, testing, and monitoring are carried out in a controlled medical environment, helping maintain stem cell purity before therapy.

Ethical considerations are followed alongside medical treatment by our professional practitioners, with documentation, sterilization, and quality-checking processes carried out consistently.

21

Hypoxic Ischemic Encephalopathy Follow-Up Care

Post-treatment monitoring is an essential part of care in HIE. Regular follow-up sessions allow doctors to track changes in motor function, muscle coordination, feeding, sleep, and behavioral patterns. Specific therapies or exercises may be recommended as recovery progresses, and online or in-person follow-up assistance is available to national and international patients alike, with medical staff on hand to answer questions throughout the process.

22

Supportive Therapies Sometimes Used Alongside Hypoxic Ischemic Encephalopathy Treatment

Supportive therapy plays an important role alongside stem cell treatment, helping infants build skills for daily function and supporting gradual development.

  • Occupational Therapy — Supports hand-eye coordination, balance, and independence with daily activities.
  • Sensory Integration Therapy — Helps improve the child's ability to process and respond to touch, sound, and light.
  • Dietary Modifications — Appropriate nutrition supports stamina, physical endurance, and cognitive function during recovery.
  • Psychological Support — Counseling helps both patients and parents manage the stress that can accompany a chronic condition.
  • Speech Therapy — Supports articulation, feeding, and swallowing skills affected by nerve involvement.
  • Hyperbaric Oxygen Therapy — Provides additional oxygen to body tissues, potentially supporting the brain's healing process.
23

Why Some International Hypoxic Ischemic Encephalopathy Patients Consider India

India offers a growing reputation for advanced, affordable care, including stem cell therapy for hypoxic ischemic encephalopathy — a condition often linked to birth asphyxia that can lead to significant neurological challenges. Patients from countries including Europe, the USA, and the UK travel to India seeking care aimed at supporting brain tissue repair and improving neurological function.

  • Experienced Medical Professionals — A large pool of qualified doctors, specialists, and researchers with global experience in stem cell therapy for neonatal and neurological conditions.
  • Advanced Technology and Research — Modern diagnostic tools and current advancements in stem cell research support accurate diagnosis and treatment.
  • Cost-Effective Treatment — Costs are considerably lower than in many Western countries.
  • Personalized Treatment Plans — Care tailored to each patient's medical history, symptoms, and condition.
  • International Patient Services — Visa assistance, travel arrangements, language support, and post-treatment care for a smoother experience.
24

Selected Hypoxic Ischemic Encephalopathy Research & Publications

  • Autologous Cord Blood for Neonatal HIE: Phase II Pilot RCT — Cotten CM et al. | Pediatrics — https://doi.org/10.1542/peds.2013-1016
  • MSC Combined with Hypothermia for HIE: Neuroprotection Enhancement — Donega V et al. | Pediatric Research — https://doi.org/10.1038/pr.2014.134
  • Exosome Therapy for Neonatal HIE: Myelination and Axonal Regeneration — Ophelders DR et al. | Stem Cells Translational Medicine — https://doi.org/10.5966/sctm.2015-0197
  • Allogeneic Cord Blood for HIE: NEURECOVER Phase I Trial — Thornton C et al. | Frontiers in Neurology — https://doi.org/10.3389/fneur.2018.00261
  • Intranasal MSC for Neonatal Hypoxia-Ischemia: Brain Repair — Donega V et al. | Pediatric Research — https://doi.org/10.1038/pr.2013.14
  • Human MSC Reduce Periventricular Leukomalacia in Preterm HIE Models — Pimentel-Coelho PM et al. | Annals of Neurology — https://doi.org/10.1002/ana.22281
  • Cord Blood Cell Infusion for Term HIE: Systematic Review — Wu YW et al. | Developmental Medicine & Child Neurology — https://doi.org/10.1111/dmcn.13344
  • MSC-Derived Exosomes Reduce Microglial Activation in Neonatal HIE — Hagberg H et al. | Brain Pathology — https://doi.org/10.1111/bpa.12618
  • BM-MSC IV Therapy in Neonatal Hypoxic-Ischemic Brain Injury: Ovine Model — McCullough LD et al. | Developmental Neuroscience — https://doi.org/10.1159/000497698
  • Oligodendrocyte Progenitor Transplantation for White Matter Injury After HIE — Larpthaveesarp A et al. | ASN Neuro — https://doi.org/10.1177/1759091419881768
25

Hypoxic Ischemic Encephalopathy Research References

  • National Library of Medicine (PubMed) — Stem Cell Therapy in Neonates with Hypoxic-Ischemic Encephalopathy: A Systematic Review and Meta-analysis — https://pubmed.ncbi.nlm.nih.gov/40847199/
  • National Center for Biotechnology Information (NCBI) — Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review of Preclinical Studies — https://pmc.ncbi.nlm.nih.gov/articles/PMC8003344/
  • PubMed — Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy — https://pubmed.ncbi.nlm.nih.gov/25161645/
  • PubMed — The Fate and Prospects of Stem Cell Therapy in the Treatment of Hypoxic-Ischemic Encephalopathy — https://pubmed.ncbi.nlm.nih.gov/37161514/
  • PubMed — Neonatal Hypoxic-Ischemic Encephalopathy: Emerging Therapeutic Strategies Based on Pathophysiologic Phases of the Injury — https://pubmed.ncbi.nlm.nih.gov/29681183/
  • World Health Organization (WHO) — Rehabilitation Services — https://www.who.int/news-room/fact-sheets/detail/rehabilitation
  • MedlinePlus — Hyperbaric Oxygen Therapy — https://medlineplus.gov/hyperbaricoxygentherapy.html

Treatment Disclaimer: We provide consultation, case evaluation, and patient support services in the field of regenerative medicine. As per current medical guidelines in India, stem cell-based interventions (other than approved indications) are considered investigational and are available only within regulated clinical research settings. For patients exploring broader options, we also assist in facilitating access to treatment pathways, including internationally accredited centers where different regulatory frameworks may apply.

26

Conclusion: Stem Cell Therapy for Hypoxic Ischemic Encephalopathy

Topic 26 of 26

Hypoxic ischemic encephalopathy can affect a child's physical, cognitive, and emotional development in lasting ways. Stem cell therapy, combined with consistent rehabilitation and supportive care, is being explored by families as a complementary option aimed at improving quality of life over time, though it remains investigational. Because responses to treatment differ from child to child, ongoing medical supervision and family support remain essential throughout the recovery journey.

Still deciding? ★★★★★ 4.9/5 from 193+ verified patients A free medical review shows whether it's worth pursuing for your specific case — no obligation.

Not sure if this applies to your case?

Share your diagnosis and reports, and our medical team will get back to you with a free, doctor-reviewed opinion on Hypoxic Ischemic Encephalopathy — no obligation.

  • Reviewed by our in-house medical team
  • Doctor-reviewed reply within 24–48 hours
  • No cost and no obligation to proceed
  • Your information is kept confidential

Get Your Free Evaluation

1. Your details 2. Your case
Common Questions

Frequently Asked Questions

HIE is a type of brain injury that occurs when an infant's brain doesn't receive enough oxygen and blood flow around the time of birth. It can lead to significant neurological impairment affecting motor skills, cognitive development, and overall brain function. Symptoms vary by severity and can include seizures, poor muscle tone, feeding difficulties, and developmental delays.

Stem cells have the potential to help repair and regenerate damaged brain tissue in infants with HIE. They can differentiate into cell types such as neurons and glial cells, and release neurotrophic factors that support neurogenesis, help reduce inflammation, and protect existing neurons from further damage.

Improvements vary depending on the severity of the condition and timing of intervention, and can include enhanced motor function, reduced seizure activity, and better cognitive and sensory development. Regular follow-up with developmental assessments helps track progress, though ongoing therapy and support are often still needed to maximize benefits.

Challenges include ensuring safe and effective delivery of cells to the target brain tissue, minimizing the risk of immune reactions (particularly with donor cells), and preventing inappropriate cell differentiation. Long-term safety and efficacy require further study through clinical trials, and standardized protocols for preparation, administration, and monitoring are still being developed.

The main types studied include mesenchymal stem cells (MSCs), neural stem cells (NSCs), and induced pluripotent stem cells (iPSCs), derived from sources such as bone marrow, umbilical cord blood, or adipose tissue. Administration methods include intravenous injection, intrathecal injection into the cerebrospinal fluid, and intra-arterial injection. The choice depends on the specific case and treatment goals.

Not fully sure which diagnosis fits? Send both reports and our medical team will confirm which condition applies — often within 24–48 hours.

If a caregiver or patient you know is dealing with a different diagnosis, this covers the same treatment approach for another common condition:

All Treatments

Explore Other Categories

Editorial & Medical Standards

Medically reviewed by the Stem Cell Care India clinical team. Last reviewed 2 September 2026. Written by Nishat Arfin · Scientific review by Tabish Iqbal · Medically approved by the Stem Cell Care India Medical Team.


Talk to a case coordinator about your specific condition and treatment options.

24–48hFrom sending your reports to a doctor-reviewed answer
10,000+Patients treated across 65+ countries
4.9 / 5From 193+ verified Google reviews

Talk to a case coordinator about your specific condition and treatment options.

24–48hFrom sending your reports to a doctor-reviewed answer
10,000+Patients treated across 65+ countries
4.9 / 5From 196+ verified Google reviews

Patient stories — Neurological

UK Patient Undergoes Second Stem Cell Session for Ataxia Type 2

Treatment for Parkinson’s: Stem Cell Therapy via Intrathecal Injection

The Patient Father Shares His Experience For Cerebral Palsy

The Patient Father Shares his Experience for Cerebral Palsy

See all patient videos →